
Jeffrey S. Lundgren
Supervisory Patent Examiner (ID: 9173, Phone: (571)272-5541 , Office: P/1629 )
| Most Active Art Unit | 1639 |
| Art Unit(s) | 1639, 1629, 1631 |
| Total Applications | 522 |
| Issued Applications | 119 |
| Pending Applications | 144 |
| Abandoned Applications | 259 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11364013
[patent_doc_number] => 20170001995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-05
[patent_title] => 'COMPOUNDS FOR THE TREATMENT OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 15/019135
[patent_app_country] => US
[patent_app_date] => 2016-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 33080
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15019135
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/019135 | COMPOUNDS FOR THE TREATMENT OF CANCER | Feb 8, 2016 | Abandoned |
Array
(
[id] => 10820531
[patent_doc_number] => 20160166696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-16
[patent_title] => 'Stable Anti-inflammatory Solutions for Injection'
[patent_app_type] => utility
[patent_app_number] => 14/971154
[patent_app_country] => US
[patent_app_date] => 2015-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12481
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14971154
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/971154 | Stable Anti-inflammatory Solutions for Injection | Dec 15, 2015 | Abandoned |
Array
(
[id] => 11053343
[patent_doc_number] => 20160250305
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-01
[patent_title] => 'Method for Immunomodulation of using Aza-podophyllotoxin derivatives'
[patent_app_type] => utility
[patent_app_number] => 14/929641
[patent_app_country] => US
[patent_app_date] => 2015-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 3572
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14929641
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/929641 | Method for Immunomodulation of using Aza-podophyllotoxin derivatives | Nov 1, 2015 | Abandoned |
Array
(
[id] => 11512892
[patent_doc_number] => 20170079966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-23
[patent_title] => 'INHIBITION OF TUMOR CELL INTERACTIONS WITH THE MICROENVIRONMENT RESULTING IN A REDUCTION IN TUMOR GROWTH AND DISEASE PROGRESSION'
[patent_app_type] => utility
[patent_app_number] => 14/883109
[patent_app_country] => US
[patent_app_date] => 2015-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 12992
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14883109
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/883109 | INHIBITION OF TUMOR CELL INTERACTIONS WITH THE MICROENVIRONMENT RESULTING IN A REDUCTION IN TUMOR GROWTH AND DISEASE PROGRESSION | Oct 13, 2015 | Abandoned |
Array
(
[id] => 12656743
[patent_doc_number] => 20180110747
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-26
[patent_title] => USE OF THIA OXO COMPOUNDS FOR LOWERING APO C3
[patent_app_type] => utility
[patent_app_number] => 15/562554
[patent_app_country] => US
[patent_app_date] => 2015-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11588
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -77
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15562554
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/562554 | USE OF THIA OXO COMPOUNDS FOR LOWERING APO C3 | Mar 31, 2015 | Abandoned |
Array
(
[id] => 11335490
[patent_doc_number] => 20160361245
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-15
[patent_title] => 'COSMETIC COMPOSITIONS OF MITOCHONDRIALLY TARGETED ANTIOXIDANTS'
[patent_app_type] => utility
[patent_app_number] => 15/121600
[patent_app_country] => US
[patent_app_date] => 2015-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7585
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15121600
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/121600 | COSMETIC COMPOSITIONS OF MITOCHONDRIALLY TARGETED ANTIOXIDANTS | Feb 24, 2015 | Abandoned |
Array
(
[id] => 10354869
[patent_doc_number] => 20150239874
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-27
[patent_title] => 'COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE'
[patent_app_type] => utility
[patent_app_number] => 14/562965
[patent_app_country] => US
[patent_app_date] => 2014-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24843
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14562965
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/562965 | COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE | Dec 7, 2014 | Abandoned |
Array
(
[id] => 11107582
[patent_doc_number] => 20160304553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-20
[patent_title] => 'ARAMCHOL SALTS'
[patent_app_type] => utility
[patent_app_number] => 15/100993
[patent_app_country] => US
[patent_app_date] => 2014-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10677
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15100993
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/100993 | ARAMCHOL SALTS | Dec 3, 2014 | Abandoned |
Array
(
[id] => 10368325
[patent_doc_number] => 20150253330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-10
[patent_title] => 'PRE-SELECTION OF SUBJECTS FOR THERAPEUTIC TREATMENT WITH AN HSP90 INHIBITOR BASED ON HYPOXIC STATUS'
[patent_app_type] => utility
[patent_app_number] => 14/515088
[patent_app_country] => US
[patent_app_date] => 2014-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 30578
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14515088
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/515088 | PRE-SELECTION OF SUBJECTS FOR THERAPEUTIC TREATMENT WITH AN HSP90 INHIBITOR BASED ON HYPOXIC STATUS | Oct 14, 2014 | Abandoned |
Array
(
[id] => 9812982
[patent_doc_number] => 20150024927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-22
[patent_title] => 'CHEMISORPTION OF ETHYL ACETATE DURING HYDROGENATION OF ACETIC ACID TO ETHANOL'
[patent_app_type] => utility
[patent_app_number] => 14/493794
[patent_app_country] => US
[patent_app_date] => 2014-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11034
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14493794
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/493794 | CHEMISORPTION OF ETHYL ACETATE DURING HYDROGENATION OF ACETIC ACID TO ETHANOL | Sep 22, 2014 | Abandoned |
Array
(
[id] => 11986182
[patent_doc_number] => 20170290337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-12
[patent_title] => 'Herbicidal Pyridino-/Pyrimidino-Thiazoles'
[patent_app_type] => utility
[patent_app_number] => 15/514048
[patent_app_country] => US
[patent_app_date] => 2014-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19945
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15514048
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/514048 | Herbicidal Pyridino-/Pyrimidino-Thiazoles | Sep 17, 2014 | Abandoned |
Array
(
[id] => 11016705
[patent_doc_number] => 20160213658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-28
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS OF ROFLUMILAST AND PROCESS FOR PREPARATION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/917709
[patent_app_country] => US
[patent_app_date] => 2014-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2400
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14917709
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/917709 | PHARMACEUTICAL COMPOSITIONS OF ROFLUMILAST AND PROCESS FOR PREPARATION THEREOF | Sep 10, 2014 | Abandoned |
Array
(
[id] => 11089832
[patent_doc_number] => 20160286800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-06
[patent_title] => 'STABILIZED COMPOSITION OF AN OXIDIZER AND METAL IONS, METHOD AND USE FOR IMPROVING DISEASE CONTROL, AND KIT FOR PREPARING SAID COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 15/023187
[patent_app_country] => US
[patent_app_date] => 2014-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25909
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15023187
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/023187 | STABILIZED COMPOSITION OF AN OXIDIZER AND METAL IONS, METHOD AND USE FOR IMPROVING DISEASE CONTROL, AND KIT FOR PREPARING SAID COMPOSITION | Aug 24, 2014 | Abandoned |
Array
(
[id] => 10981666
[patent_doc_number] => 20160178610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-23
[patent_title] => 'New screening method for the treatment Friedreich\'s ataxia'
[patent_app_type] => utility
[patent_app_number] => 14/910590
[patent_app_country] => US
[patent_app_date] => 2014-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 27285
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14910590
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/910590 | New screening method for the treatment Friedreich's ataxia | Aug 4, 2014 | Abandoned |
Array
(
[id] => 10799114
[patent_doc_number] => 20160145270
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-26
[patent_title] => 'COMPOUNDS FOR TREATING SPINAL MUSCULAR ATROPHY'
[patent_app_type] => utility
[patent_app_number] => 14/899397
[patent_app_country] => US
[patent_app_date] => 2014-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28735
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14899397
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/899397 | COMPOUNDS FOR TREATING SPINAL MUSCULAR ATROPHY | Jun 22, 2014 | Abandoned |
Array
(
[id] => 10774669
[patent_doc_number] => 20160120825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-05
[patent_title] => 'STABLE CRYSTAL X-FORM AGOMELATINE TABLET AND PREPARATION METHOD THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/896087
[patent_app_country] => US
[patent_app_date] => 2014-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7076
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14896087
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/896087 | STABLE CRYSTAL X-FORM AGOMELATINE TABLET AND PREPARATION METHOD THEREOF | May 25, 2014 | Abandoned |
Array
(
[id] => 9699539
[patent_doc_number] => 20140249225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-04
[patent_title] => 'METHODS OF REDUCING OR PREVENTING OXIDATIVE MODIFICATION OF MEMBRANE POLYUNSATURATED FATTY ACIDS'
[patent_app_type] => utility
[patent_app_number] => 14/193531
[patent_app_country] => US
[patent_app_date] => 2014-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 20683
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14193531
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/193531 | METHODS OF REDUCING OR PREVENTING OXIDATIVE MODIFICATION OF MEMBRANE POLYUNSATURATED FATTY ACIDS | Feb 27, 2014 | Abandoned |
Array
(
[id] => 10467071
[patent_doc_number] => 20150352086
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-10
[patent_title] => 'HEAT SHOCK PROTEIN (HSP) INHIBITION AND MONITORING EFFECTIVENESS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/759477
[patent_app_country] => US
[patent_app_date] => 2014-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 23285
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14759477
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/759477 | HEAT SHOCK PROTEIN (HSP) INHIBITION AND MONITORING EFFECTIVENESS THEREOF | Jan 6, 2014 | Abandoned |
Array
(
[id] => 8964244
[patent_doc_number] => 20130203846
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-08
[patent_title] => 'PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING ALS'
[patent_app_type] => utility
[patent_app_number] => 13/727661
[patent_app_country] => US
[patent_app_date] => 2012-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 36564
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13727661
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/727661 | PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING ALS | Dec 26, 2012 | Abandoned |
Array
(
[id] => 9538613
[patent_doc_number] => 20140163260
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-12
[patent_title] => 'METHOD FOR CARRYING OUT EXOTHERMIC CATALYTIC REACTIONS AND A REACTOR FOR USE IN THE METHOD'
[patent_app_type] => utility
[patent_app_number] => 14/125922
[patent_app_country] => US
[patent_app_date] => 2012-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2835
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14125922
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/125922 | METHOD FOR CARRYING OUT EXOTHERMIC CATALYTIC REACTIONS AND A REACTOR FOR USE IN THE METHOD | Jun 14, 2012 | Abandoned |